
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PTNT | OTC Markets | USD | Delayed | |
0KF3 | London | USD | Real-time |
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Sheryl A. Kingsberg | - | - | Member of Female Sexual Dysfunction Expert Panel |
Susan G. Kornstein | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Carl Spana | 63 | 1996 | Co-Founder, President, CEO & Director |
Raymond C. Rosen | - | 2005 | Member of Female Sexual Dysfunction Expert Panel |
John K. A. Prendergast | 71 | 1996 | Independent Non-Executive Chairman |
Alan W. Dunton | 71 | 2011 | Independent Director |
Brooke M. Faught | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Anita H. Clayton | - | - | Member of Female Sexual Dysfunction Expert Panel |
Michael A. Perelman | - | 2005 | Member of Female Sexual Dysfunction Expert Panel |
Ricki Pollycove | 70 | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
James Pfaus | - | - | Member of Female Sexual Dysfunction Expert Panel |
Murray Freedman | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Lisa Larkin | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Leonard R. Derogatis | - | - | Member of Female Sexual Dysfunction Expert Panel |
Robin Kroll | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Cindy M. Meston | - | - | Member of Female Sexual Dysfunction Expert Panel |
Susan Kellogg-Spadt | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Sharon J. Parish | - | - | Member of Female Sexual Dysfunction Expert Panel |
Arlene M. Morris | 74 | 2015 | Independent Director |
Risa Kagan | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Martin M. Miner | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Stanley E. Althof | - | - | Member of Female Sexual Dysfunction Expert Panel |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review